Skip to main content
AACE Endocrine University Year 1 2025 Main banner
Program Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

Industry

Understanding CRYSVITA® (burosumab-twza), an FGF23Targeted Therapy sponsored by Kyowa Kirin

Friday, February 21, 2025
9:00 AM – 9:45 AM East Coast USA Time

    Presenter(s)

  • Laila Tabatabai, MD

    Associate Professor of Clinical Medicine, Houston Methodist Endocrinology; Director, Houston Methodist Bone Health Initiative
    Houston Methodist Hospital
    Houston, Texas

    • Session Moderator(s)

  • Beverly Haverkamp, MS, RD, CDCES

    Thought Leader Liaison
    Kyowa Kirin

• Understanding the manifestation and management of X-linked hypophosphatemia (XLH) in adult patients
• Proposed mechanism of action of CRYSVITA
• Adult XLH clinical studies

This program is sponsored by Kyowa Kirin.